Aiforia Technologies Oyj
F:L6J
Aiforia Technologies Oyj
Aiforia Technologies Oyj provides deep learning artificial intelligence (AI) software to pathologists and scientists in preclinical and clinical labs. The company is headquartered in Helsinki, Etela-Suomen and currently employs 74 full-time employees. The company went IPO on 2021-12-10. Aiforia’s business model is based on the development and utilization of AI models in the analysis of tissue and cell samples relating to medical research and diagnostics. The Company’s cloud-based deep learning artificial intelligence solutions aim to increase the speed, accuracy, and consistency of analyzing medical images across a wide range of fields. Aiforia's solutions aim to automate routine tasks and provide artificial intelligence to support the diagnostic workflow. The product offering consists of Aiforia Create, a solution with which the end user can develop their own AI model for any image analysis application simply by annotating images to train the AI model what to identify, quantify, or measure.
Aiforia Technologies Oyj provides deep learning artificial intelligence (AI) software to pathologists and scientists in preclinical and clinical labs. The company is headquartered in Helsinki, Etela-Suomen and currently employs 74 full-time employees. The company went IPO on 2021-12-10. Aiforia’s business model is based on the development and utilization of AI models in the analysis of tissue and cell samples relating to medical research and diagnostics. The Company’s cloud-based deep learning artificial intelligence solutions aim to increase the speed, accuracy, and consistency of analyzing medical images across a wide range of fields. Aiforia's solutions aim to automate routine tasks and provide artificial intelligence to support the diagnostic workflow. The product offering consists of Aiforia Create, a solution with which the end user can develop their own AI model for any image analysis application simply by annotating images to train the AI model what to identify, quantify, or measure.
This earnings call has not been analyzed yet.
If you’d like us to analyze this earnings call, click the "Request Earnings Call Analysis" button below.
